- Home
- IVDA vs OGEN Comparison
IVDA vs OGEN Comparison
Compare IVDA & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- OGEN
- Stock Information
- Founded
- IVDA 2003
- OGEN 1996
- Country
- IVDA United States
- OGEN United States
- Employees
- IVDA N/A
- OGEN N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- OGEN Health Care
- Exchange
- IVDA Nasdaq
- OGEN Nasdaq
- Market Cap
- IVDA 3.5M
- OGEN 4.5M
- IPO Year
- IVDA N/A
- OGEN N/A
- Fundamental
- Price
- IVDA $1.64
- OGEN $0.34
- Analyst Decision
- IVDA
- OGEN
- Analyst Count
- IVDA 0
- OGEN 0
- Target Price
- IVDA N/A
- OGEN N/A
- AVG Volume (30 Days)
- IVDA 40.0K
- OGEN 389.1K
- Earning Date
- IVDA 11-20-2024
- OGEN 11-07-2024
- Dividend Yield
- IVDA N/A
- OGEN N/A
- EPS Growth
- IVDA N/A
- OGEN N/A
- EPS
- IVDA N/A
- OGEN N/A
- Revenue
- IVDA $3,779,754.00
- OGEN $7,466.00
- Revenue This Year
- IVDA $23.76
- OGEN N/A
- Revenue Next Year
- IVDA $229.89
- OGEN N/A
- P/E Ratio
- IVDA N/A
- OGEN N/A
- Revenue Growth
- IVDA N/A
- OGEN N/A
- 52 Week Low
- IVDA $1.40
- OGEN $0.29
- 52 Week High
- IVDA $10.16
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- IVDA 41.96
- OGEN 37.15
- Support Level
- IVDA $1.40
- OGEN $0.29
- Resistance Level
- IVDA $1.72
- OGEN $0.45
- Average True Range (ATR)
- IVDA 0.10
- OGEN 0.04
- MACD
- IVDA 0.06
- OGEN 0.02
- Stochastic Oscillator
- IVDA 75.00
- OGEN 28.88
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.